News Headlines Article

Emergency epinephrine syringes in short supply
Modern Healthcare

The Food and Drug Administration is reporting shortages of pre-filled syringes of epinephrine, which are most commonly used to treat individuals who are in cardiac arrest. The FDA’s drug shortage database shows that both Rancho Cucamonga, Calif.-based Amphastar Pharmaceuticals and Lake Forest, Ill.-based Hospira are reporting shortages of the injections. The syringes are in intermittent supply and it’s not expected that will change anytime soon, said Stacey Winston, senior director of pharmacy contracting solutions at Amerinet, a group purchasing organization.

Commands